Gene set enrichment analysis (GSEA) indicated that ARNT was involved in regulating glycolysis, hypoxia, the p53 pathway, and interferon alpha response, suggesting ARNT may serve as a marker of malignancy in GBM. This evidence concerns the gene TP53 and glioblastoma.